JANX icon

Janux Therapeutics

155 hedge funds and large institutions have $1.87B invested in Janux Therapeutics in 2024 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 58 increasing their positions, 33 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

more capital invested

Capital invested by funds: $ → $

4.3% more ownership

Funds ownership: 81.95%86.26% (+4.3%)

8% less call options, than puts

Call options by funds: $4.12M | Put options by funds: $4.46M

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
155
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.12M
Puts
$4.46M
Net Calls
Net Calls Change

Top Buyers

1 +$65.5M
2 +$61.6M
3 +$42M
4
VPC
Vestal Point Capital
New York
+$30.4M
5
BlackRock
BlackRock
New York
+$27.2M

Top Sellers

1 -$104M
2 -$54.3M
3 -$37.6M
4
Citadel Advisors
Citadel Advisors
Florida
-$33.2M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$18.8M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$362K
102
$333K
103
$331K
104
$331K
105
$327K
106
$327K
107
$318K
108
$310K
109
$294K
110
$263K
111
$255K
112
$245K
113
$243K
114
$242K
115
$241K
116
$237K
117
$236K
118
$235K
119
$231K
120
$226K
121
$221K
122
$215K
123
$211K
124
$204K
125
$151K